“Adenosine Monophosphate-Activated Protein Kinase (AMPK) as a New Target for Antidiabetic Drugs: A Review on Metabolic, Pharmacological and Chemical Considerations ” (2023) The Review of Diabetic Studies, 6(2). Available at: https://diabeticstudies.org/index.php/RDS/article/view/263 (Accessed: 13 September 2025).